Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01627184 · ClinicalTrials.gov registry record
Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus
A clinical trial, sponsored by DexCom.
- Completed
- Registry status
- 13
- Enrollment target
NCT01627184: Completed study, sponsored by DexCom.
NCT01627184 is a clinical trial that has completed, run by DexCom. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01627184 has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate CGM glycemic control using the Dexcom G4 system as well as system performance during high levels of activity and home use by adult athletes with insulin-requiring diabetes mellitus, over an extended period of time.
Primary Outcome
The proportion of time spent in euglycemia zone as well as hypoglycemia zone will be determined from the system glucose readings, particularly during subject's high levels of activity. Longitudinal data analysis methods will be used to assess the within-subject and between-subject effects of the glycemic control for the study population.
Interventions
- DEVICE Dexcom G4 CGM System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-06 |
What the finished NCT01627184 record still lists
NCT01627184 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Dexcom G4 CGM System is the first listed.
NCT01627184 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01627184 about?
NCT01627184 is a clinical study titled "Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus". The purpose of this study is to evaluate CGM glycemic control using the Dexcom G4 system as well as system performance during high levels of activity and home use by adult athletes with insulin-requiring diabetes mellitus, over an extended period of time.
What is the current status of trial NCT01627184?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2012-05. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01627184?
The interventions under investigation include: Dexcom G4 CGM System (DEVICE).
Who is sponsoring clinical trial NCT01627184?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia